Bioavailability Containment Marketing Regulation 
The Pharma Data
JANUARY 3, 2021
The information in the press release is information that Nanoform is obliged to make public pursuant to the EU Market Abuse Regulation. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). . +46 7686 650 11. 2 Proof of Concept.
The Pharma Data
NOVEMBER 26, 2020
This novel nanoparticle formation technology provides hope for improving the possibilities and probabilities of developing better medicines for patients and it expands Nanoform’s reach into the growing biological market. Finnish time. About Nanoform. Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 562 1806.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
DECEMBER 3, 2020
Maribavir, an orally bioavailable anti-CMV compound, is the only antiviral agent presently in Phase 3 development for the treatment of post-transplant patients with CMV in SOT or HSCT. In transplant recipients, reactivation of CMV can lead to serious consequences including loss of the transplanted organ and, in extreme cases, can be fatal.
Pharmaceutical Technology
NOVEMBER 24, 2022
This is due to the fact that the current Good Manufacturing Practice (cGMP) standards required for human studies involve a significant investment in infrastructure and quality systems in order to efficiently comply with all national and international regulations. How are human ADME studies designed?
The Pharma Data
JANUARY 27, 2021
Clinical Studies XPhyto’s drug formulation business is focused on neurological indications with strong market demand and the potential for improved patient outcomes. Psychedelics could provide a major improvement over currently available therapeutics for a global market with unmet medical need.
Pharmaceutical Technology
MARCH 7, 2023
Due to rising healthcare spending, launch of novel treatments, and the rise of chronic diseases in an aging population, the global pharmaceutical packaging equipment market is rapidly expanding. Recent analysis valued the market [i] at USD 8.5 Safety issues must also be addressed, such as containment and potential ignition factors.
Pharmaceutical Technology
FEBRUARY 3, 2023
There are a number of reasons why OSD forms dominate the market, not least because they are simple to administer, and it is easy to differentiate one OSD product from another. As with any pharmaceutical manufacturing, challenges can be many, and processes are highly regulated.
Expert insights. Personalized for you.
52 
Let's personalize your content